Adalimumab in CD
Safety and Tolerability of Concurrent Natalizumab Treatment for Patients with Crohn’s Disease Not in Remission While Receiving Infliximab
Certolizumab in CD
Probiotics in CD for postop recurrence
Infliximab in paediatric CD
Synbiotics in CD for postop recurrence
Topical tacrolimus in perianal Crohn’s disease